153 related articles for article (PubMed ID: 27097240)
1. Diffuse Rash After the Administration of Carboplatin and Paclitaxel.
Hazan E; Santa E; Sahu J
Am J Dermatopathol; 2016 May; 38(5):365. PubMed ID: 27097240
[No Abstract] [Full Text] [Related]
2. Diffuse Rash After the Administration of Carboplatin and Paclitaxel: Answer.
Hazan E; Santa E; Sahu J
Am J Dermatopathol; 2016 May; 38(5):393. PubMed ID: 27097241
[No Abstract] [Full Text] [Related]
3. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
Pectasides D; Pectasides E; Papaxoinis G; Xiros N; Sykiotis C; Papachristodoulou A; Tountas N; Panayiotides J; Economopoulos T
Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
[TBL] [Abstract][Full Text] [Related]
4. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus.
Toyoshima M; Akahira J; Matsunaga G; Niikura H; Ito K; Yaegashi N; Tase T
Gynecol Oncol; 2004 Sep; 94(3):774-8. PubMed ID: 15350372
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
[TBL] [Abstract][Full Text] [Related]
6. Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.
Aghajanian C; Sill MW; Secord AA; Powell MA; Steinhoff M
Gynecol Oncol; 2012 Sep; 126(3):424-7. PubMed ID: 22634397
[TBL] [Abstract][Full Text] [Related]
7. Hypersensitivity Reaction to Carboplatin in Gynecologic Cancer: A Case Report and a Review of the Literature.
Aoyama Y; Ueda T; Kuradome Y; Hoshino K; Harada H; Kinjo Y; Murakami M; Kagami S; Yoshino K
J UOEH; 2021; 43(1):81-86. PubMed ID: 33678789
[TBL] [Abstract][Full Text] [Related]
8. Acquired generalised anhidrosis presenting with heat retention after carboplatin and paclitaxel treatment.
Endo Y; Nakamizo S; Fujisawa A; Tanioka M; Kabashima K; Miyachi Y
Eur J Dermatol; 2013; 23(6):887-8. PubMed ID: 24192525
[No Abstract] [Full Text] [Related]
9. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
Cohen RB; Langer CJ; Simon GR; Eisenberg PD; Hainsworth JD; Madajewicz S; Cosgriff TM; Pierce K; Xu H; Liau K; Healey D
Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion.
Roque DR; Matei D
J Clin Oncol; 2022 Mar; 40(9):924-926. PubMed ID: 35044808
[No Abstract] [Full Text] [Related]
11. Phase II study of paclitaxel in combination with carboplatin for patients with recurrent or persistent uterine sarcoma.
Yoo HJ; Lim MC; Lim S; Park JY; Kang S; Park SY; Seo SS
Arch Gynecol Obstet; 2012 Dec; 286(6):1529-35. PubMed ID: 22825691
[TBL] [Abstract][Full Text] [Related]
12. Beau's lines.
Chang CC; Wu CC
QJM; 2013 Apr; 106(4):383. PubMed ID: 22408154
[No Abstract] [Full Text] [Related]
13. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
Waseem H; Henriquez Felipe C; Hashmi AT; Ansar M; Batool A; Saverimuthu A; Kamholz SL
Am J Ther; 2019; 26(5):e653-e655. PubMed ID: 30418222
[No Abstract] [Full Text] [Related]
14. Abandon ifosfamide-based regimen and use paclitaxel-carboplatin regimen for the treatment of uterine carcinosarcoma.
Yang ST; Wang PH
J Chin Med Assoc; 2022 May; 85(5):649-650. PubMed ID: 35385437
[No Abstract] [Full Text] [Related]
15. Erlotinib-induced generalized eczema craquelé and follicular rash sparing the previous radiation field.
Chiu HY; Cheng YP; Jee SH; Tsai TF
Clin Exp Dermatol; 2012 Dec; 37(8):922-4. PubMed ID: 22731795
[No Abstract] [Full Text] [Related]
16. Adalimumab-associated psoriasiform rash in an African-American patient.
Chao Y; Hutto J; Keshvani N; Makris UE
BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32958552
[No Abstract] [Full Text] [Related]
17. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
Obermair A; Mileshkin L; Bolz K; Kondalsamy-Chennakesavan S; Cheuk R; Vasey P; Wyld D; Goh J; Nicklin JL; Perrin LC; Sykes P; Janda M
Gynecol Oncol; 2011 Feb; 120(2):179-84. PubMed ID: 21126755
[TBL] [Abstract][Full Text] [Related]
18. Acneiform Rash With Ramucirumab and Paclitaxel in a Patient With Recurrent Esophageal Cancer.
Moore DC
Am J Ther; 2018; 25(5):e557-e558. PubMed ID: 28767454
[No Abstract] [Full Text] [Related]
19. Phase I, pharmacokinetic, and biological study of erlotinib in combination with paclitaxel and carboplatin in patients with advanced solid tumors.
Patnaik A; Wood D; Tolcher AW; Hamilton M; Kreisberg JI; Hammond LA; Schwartz G; Beeram M; Hidalgo M; Mita MM; Wolf J; Nadler P; Rowinsky EK
Clin Cancer Res; 2006 Dec; 12(24):7406-13. PubMed ID: 17189413
[TBL] [Abstract][Full Text] [Related]
20. Radiation recall phenomenon presenting as myositis triggered by carboplatin plus paclitaxel and related literature review.
Maeng CH; Park JS; Lee SA; Kim DH; Yun DH; Yoo SD; Kim HS; Chon J
J Cancer Res Ther; 2014; 10(4):1093-7. PubMed ID: 25579560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
